The Association for Research in Vision and Ophthalmology held its annual conference in Orlando, FL, last week and Optometry Times’ sister publication, Ophthalmology Times, was there to catch up on the latest research on glaucoma, AMD, and other diseases.
I sometimes wonder why, in the rush to build the medical model, so many of my colleagues seemingly abandon the retail aspects of our profession. Many ODs seem to want to forget or diminish that our historical contribution to vision has been mainly centered around the correction, refractive, and binocular vision function and development.
The next time I see a patient with diabetic retinopathy who seems to be nonchalant or blasé regarding his condition, I’m going to say something along the lines of this: “Mr._______, this leaking of your blood vessels is going on elsewhere in your body, but your eyes just happen to be the only place we can see it without being invasive.”
The day before SECO in Atlanta, Chief Optometric Editor Ernie Bowling joined me to sit in on Allergan’s Pathways in Medical Optometry Boot Camp.
Researchers at the University of California, Los Angeles, have designed a contact lens that can release controlled amounts of a glaucoma drug, delivering more consistent dosages of the drug than eye drops.
Harry Quigley, MD, of the Wilmer Eye Institute at John Hopkins shared some of his pearls for diagnosing and treating glaucoma during a special session at SECO.
Joseph Sowka, OD, FAAO, Diplomate, shared at SECO some of his recommendations for when certain glaucoma therapy drops should be administered.
The probability of blindness due to the serious eye disease glaucoma has decreased by nearly half since 1980, according to a study recently published in Ophthalmology.
Patients will soon be able to undergo a refraction online through Opternative.com in a matter of minutes and for a fraction of the cost of a traditional exam, but the company doesn’t intend for its test to replace a complete eye exam.
A few months ago, I began to see what may be a little more progression on her OCT studies. I’m fairly confident that we’re in a good place right now as far as compliance is concerned, and I’m entering a crossroads with her regarding possibly adding therapy vs. getting a consult for a laser procedure, such as selective laser trabeculoplasty (SLT), vs. getting a cataract consult.
According to a new market report published by Transparency Market Research the global ophthalmic drugs market was valued at $16 billion in 2012 and is expected to reach an estimated value of $21.6 billion in 2018.
Ellex Medical Lasers Limited announced that it has recently acquired the canaloplasty business of US-based iScience Interventional, Inc.
The measurement and management of intraocular pressure (IOP) in patients with glaucoma is critical. Even with the onslaught of new technologies to monitor progression and make earlier diagnoses, IOP remains a crucial data point in the optometric examination.
Prevent Blindness and other eye health organizations have declared January as National Glaucoma Awareness Month. Prevent Blindness seeks to educate the public on the second leading cause of blindness, following cataracts, by providing free resources via online or by mail through its Glaucoma Learning Center.
I didn’t get up screaming. I didn’t hurl my computer across the room. I didn’t even let my inferiority complex show through the emotions I was feeling. Instead, I calmly and politely wrote a short letter to the news organization explaining what optometrists are, and that glaucoma was what I, as an optometrist, spent most of my days dealing with.
According to a recent study, women who have taken oral contraceptives for 3 or more years are twice as likely to suffer from glaucoma. What do your patients need to know?
In an effort to take the best care of my glaucoma patients that I can, I’ve made use of a few pearls that have helped me to keep calm in the face of the beast that is glaucoma.
Alcon has created an educational Web site for every stage of glaucoma for patients and caregivers.
When caring for patients with glaucoma, clinicians sometimes encounter clinical issues that are challenging and controversial.
It may be possible to view early changes in the eye before the clinical symptoms of glaucoma become apparent. A better understanding of the structural changes in glaucoma could potentially allow for a better diagnosis of the disease. Using imaging devices, such as the adaptive optics scanning laser ophthalmoscope (AOSLO), clinicians can view sharper and higher-resolution images of the eye than current clinical instruments.
Dr. Lievens shares commentary about his glaucoma lecture at the Primary Care Section of the American Academy of Optometry Diplomate Seminar in Seattle.
New perimeter combines early detection and progression monitoring of glaucoma into one compact unit.
Spectral domain optical coherence tomography (SD-OCT) is a landmark diagnostic technology. Clinicians should keep top of mind that SD-OCTs, as sophisticated as they are, do not think or interpret. That is solely the job of the clinician. In addition, visually assessing the retinal nerve fiber layer (RNFL) directly can yield more qualitative information than SD-OCT scans provide.
Patients in St. Lucia are well controlled and medication-free 1 year after SLT.
Dr. Ben Gaddie will present Under Pressure: Glaucoma Update in the Optometry Times’ second editorial Webinar in the 2013 series.
